CVD INFLUENZA 6000
CVD 流感 6000
基本信息
- 批准号:7376956
- 负责人:
- 金额:$ 45.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-03-01 至 2007-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Influenza (the flu) is a common infection caused by several related viruses. It is responsible for 20,000-40,000 deaths each year in the United States. When a new strain of flu infects people, the infection can spread around the world quickly. This worldwide spread is called a pandemic. Several pandemics have occurred in the last 100 years. These pandemics caused infection and death in a high number of people. In 1918, nearly 40 million people died in a flu pandemic. Some of the new human flu viruses come from bird flu viruses (also known as avian flu). Recently, some strains of bird flu viruses have infected people in Asia and caused a number of deaths. One of these flu strains is called A/H5N1. There is concern this new strain could cause a pandemic. Vaccines can prevent infection and disease. Vaccines work by causing the body to make proteins called antibodies that fight infection. Sometimes more than 1 dose of vaccine is needed so that the body will make enough antibodies to fight infection. Vaccines have already been developed to prevent infection with "regular" flu viruses. These flu vaccines protect against flu and the health problems it causes. They are made from parts of killed flu virus and are given as a "shot" in the arm. We are conducting this research study using a killed flu virus vaccine against the bird flu virus, A/H5N1. This vaccine is considered investigational. It has never been tested in humans. This vaccine was made the same way as "regular" flu vaccine that is given to people every year before flu season. In this study, we are trying to find out what strength of this vaccine is needed to produce protective levels of "bird flu" antibodies, which will help us decide the right dose for use in the future, if it is needed.
该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者(PI)可能从另一个NIH来源获得主要资金,因此可以在其他CRISP条目中表示。所列机构为中心,不一定是研究者所在机构。流行性感冒(流感)是由几种相关病毒引起的常见感染。在美国,每年有20,000 - 40,000人死亡。当一种新的流感病毒感染人类时,感染可以迅速蔓延到世界各地。这种全球性的传播被称为流行病。在过去的100年里发生了几次大流行病。这些大流行病造成大量人感染和死亡。1918年,近4000万人死于流感。一些新的人类流感病毒来自禽流感病毒(也称为禽流感)。最近,一些禽流感病毒株感染了亚洲的人,并造成了一些人死亡。其中一种流感病毒被称为A/H5 N1。人们担心这种新的菌株可能会引起大流行。疫苗可以预防感染和疾病。疫苗通过使身体产生称为抗体的蛋白质来对抗感染。有时需要一剂以上的疫苗,以便身体产生足够的抗体来对抗感染。疫苗已经被开发出来,以防止感染“常规”流感病毒。这些流感疫苗可以预防流感及其引起的健康问题。它们是由灭活流感病毒的一部分制成的,作为一种“注射”在手臂上。我们正在进行这项研究,使用灭活流感病毒疫苗来对抗禽流感病毒A/H5 N1。该疫苗被认为是研究性的。它从未在人体中进行过测试。这种疫苗的生产方式与每年流感季节前给人们接种的“常规”流感疫苗相同。在这项研究中,我们试图找出这种疫苗需要多大的强度才能产生保护水平的“禽流感”抗体,这将有助于我们决定未来使用的正确剂量,如果需要的话。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES D CAMPBELL其他文献
JAMES D CAMPBELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES D CAMPBELL', 18)}}的其他基金
A PHASE I STUDY OF INACTIVATED VERO CELL-CULTURE INFLUENZA A/H5N1 GIVEN ALONE
单独给予灭活 VERO 细胞培养 A/H5N1 流感的 I 期研究
- 批准号:
7608174 - 财政年份:2007
- 资助金额:
$ 45.75万 - 项目类别:
CVD INFLUENZA 17000: A PHASE I-II, RANDOMIZED, CONTROLLED, DOSE-RANGING STUDY
CVD 流感 17000:I-II 期、随机、对照、剂量范围研究
- 批准号:
7608163 - 财政年份:2007
- 资助金额:
$ 45.75万 - 项目类别:
INFLUENZA CVD 15000: EVALUATION OF A BOOSTER DOSE OF A/VIETNAM/1203/04 (H5N1)
流感 CVD 15000:A/VIETNAM/1203/04 (H5N1) 加强剂量的评估
- 批准号:
7608155 - 财政年份:2007
- 资助金额:
$ 45.75万 - 项目类别:
相似海外基金
Modelling to inform interventions during Highly Pathogenic Avian Influenza outbreaks in Great Britain
英国高致病性禽流感爆发期间的建模为干预措施提供信息
- 批准号:
BB/X016137/1 - 财政年份:2024
- 资助金额:
$ 45.75万 - 项目类别:
Research Grant
ICF - Evaluate the potential of AstraZeneca's sialic acid tag technology for treating influenza viruses with Fc molecules
ICF - 评估阿斯利康唾液酸标签技术用 Fc 分子治疗流感病毒的潜力
- 批准号:
MR/Y503459/1 - 财政年份:2024
- 资助金额:
$ 45.75万 - 项目类别:
Research Grant
ECOFLU : Understanding the ecology of Highly Pathogenic Avian Influenza in wild bird populations
ECOFLU:了解野生鸟类中高致病性禽流感的生态学
- 批准号:
NE/Y001591/1 - 财政年份:2024
- 资助金额:
$ 45.75万 - 项目类别:
Research Grant
OSIB: Metabolic cartography of influenza A virus infection and host-pathogen interaction in the natural and accidental host
OSIB:自然和意外宿主中甲型流感病毒感染和宿主-病原体相互作用的代谢制图
- 批准号:
2318557 - 财政年份:2023
- 资助金额:
$ 45.75万 - 项目类别:
Standard Grant
Syudy on highly pathogenic avian influenza infection in innate immunity
Syudy 论高致病性禽流感感染的先天免疫
- 批准号:
23H02364 - 财政年份:2023
- 资助金额:
$ 45.75万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
H5N1 influenza virulence; interference in RIG-I detection in different hosts
H5N1流感毒力;
- 批准号:
494285 - 财政年份:2023
- 资助金额:
$ 45.75万 - 项目类别:
Operating Grants
Regulation of RIG-I mediated antiviral response upon influenza A virus infection
RIG-I介导的甲型流感病毒感染抗病毒反应的调节
- 批准号:
494286 - 财政年份:2023
- 资助金额:
$ 45.75万 - 项目类别:
Operating Grants
Flu:Trailmap "Transmission and risk of avian influenza: learning more to advance preparedness"
流感:路线图“禽流感的传播和风险:了解更多信息以做好准备”
- 批准号:
BB/Y00700X/1 - 财政年份:2023
- 资助金额:
$ 45.75万 - 项目类别:
Research Grant
FLU:Trailmap: Transmission and risk of avian influenza: learning more to advance preparedness
FLU:路线图:禽流感的传播和风险:了解更多信息以做好准备
- 批准号:
BB/Y007271/1 - 财政年份:2023
- 资助金额:
$ 45.75万 - 项目类别:
Research Grant
Intranasal, rapid-acting vaccine for all seasonal and pandemic influenza viruses
针对所有季节性和大流行性流感病毒的鼻内速效疫苗
- 批准号:
10080057 - 财政年份:2023
- 资助金额:
$ 45.75万 - 项目类别:
EU-Funded